These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

174 related items for PubMed ID: 23091809

  • 21. Differential expression of transforming growth factor alpha and insulin-like growth factor II in chronic active hepatitis B, cirrhosis and hepatocellular carcinoma.
    Park BC, Huh MH, Seo JH.
    J Hepatol; 1995 Mar; 22(3):286-94. PubMed ID: 7608479
    [Abstract] [Full Text] [Related]

  • 22. Hypoxia inducible factor 1α in hepatocellular carcinoma with cirrhosis: Association with prognosis.
    Wang D, Zhang X, Lu Y, Wang X, Zhu L.
    Pathol Res Pract; 2018 Dec; 214(12):1987-1992. PubMed ID: 30274686
    [Abstract] [Full Text] [Related]

  • 23. [The effects of the expression of VEGF and KDR on the angiogenesis, growth and metastasis of hepatocellular carcinoma].
    Zhao A, Dou K, Li K, Fu Y.
    Zhonghua Wai Ke Za Zhi; 2000 Jun; 38(6):453-6. PubMed ID: 11832083
    [Abstract] [Full Text] [Related]

  • 24. Correlation of four vascular specific growth factors with carcinogenesis and portal vein tumor thrombus formation in human hepatocellular carcinoma.
    Li Q, Xu B, Fu L, Hao XS.
    J Exp Clin Cancer Res; 2006 Sep; 25(3):403-9. PubMed ID: 17167981
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Lysyl Oxidase Is Predictive of Unfavorable Outcomes and Essential for Regulation of Vascular Endothelial Growth Factor in Hepatocellular Carcinoma.
    Zhu J, Huang S, Wu G, Huang C, Li X, Chen Z, Zhao L, Zhao Y.
    Dig Dis Sci; 2015 Oct; 60(10):3019-31. PubMed ID: 26048020
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. [Expression and clinical significance of VEGF and MMP-9 in hepatocellular carcinoma].
    Zhong C, Guo RP, Shi M, Wei W, Yu WS, Li JQ.
    Ai Zheng; 2006 May; 25(5):599-603. PubMed ID: 16687082
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. IL-6, through p-STAT3 rather than p-STAT1, activates hepatocarcinogenesis and affects survival of hepatocellular carcinoma patients: a cohort study.
    Kao JT, Feng CL, Yu CJ, Tsai SM, Hsu PN, Chen YL, Wu YY.
    BMC Gastroenterol; 2015 Apr 25; 15():50. PubMed ID: 25908103
    [Abstract] [Full Text] [Related]

  • 31. Cyclooxygenase-2 expression in chronic liver diseases and hepatocellular carcinoma: an immunohistochemical study .
    Giannitrapani L, Ingrao S, Soresi M, Florena AM, La Spada E, Sandonato L, D'Alessandro N, Cervello M, Montalto G.
    Ann N Y Acad Sci; 2009 Feb 25; 1155():293-9. PubMed ID: 19250220
    [Abstract] [Full Text] [Related]

  • 32. Altered glycosylation, expression of serum haptoglobin and alpha-1-antitrypsin in chronic hepatitis C, hepatitis C induced liver cirrhosis and hepatocellular carcinoma patients.
    Mondal G, Saroha A, Bose PP, Chatterjee BP.
    Glycoconj J; 2016 Apr 25; 33(2):209-18. PubMed ID: 27034286
    [Abstract] [Full Text] [Related]

  • 33. The Prognostic Value of Circulating VEGF-A Level in Patients With Hepatocellular Cancer.
    Lacin S, Yalcin S.
    Technol Cancer Res Treat; 2020 Apr 25; 19():1533033820971677. PubMed ID: 33234055
    [Abstract] [Full Text] [Related]

  • 34. Expression and Significance of Insulin Receptor Substrate 1 in Human Hepatocellular Carcinoma.
    Gao C, Zhang H, Zhang WS, Fang L.
    Dis Markers; 2020 Apr 25; 2020():7174062. PubMed ID: 32695243
    [Abstract] [Full Text] [Related]

  • 35. Serum and tissue vascular endothelial growth factor predicts prognosis in hepatocellular carcinoma patients after partial liver resection.
    Zhong C, Wei W, Su XK, Li HD, Xu FB, Guo RP.
    Hepatogastroenterology; 2012 Apr 25; 59(113):93-7. PubMed ID: 22251524
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Expression of insulin-like growth factor II in hepatitis B, cirrhosis and hepatocellular carcinoma: its relationship with hepatitis B virus antigen expression.
    Su Q, Liu YF, Zhang JF, Zhang SX, Li DF, Yang JJ.
    Hepatology; 1994 Oct 25; 20(4 Pt 1):788-99. PubMed ID: 7927218
    [Abstract] [Full Text] [Related]

  • 38. [Expressions of Survivin and vascular endothelial growth factor in hepatocellular carcinoma and their clinical significance].
    Cui F, Chen B, Chen JZ, Huang YX, Luo RC.
    Nan Fang Yi Ke Da Xue Xue Bao; 2008 May 25; 28(5):761-3. PubMed ID: 18504198
    [Abstract] [Full Text] [Related]

  • 39. Decreased expression of hsa_circ_0003570 in hepatocellular carcinoma and its clinical significance.
    Fu L, Wu S, Yao T, Chen Q, Xie Y, Ying S, Chen Z, Xiao B, Hu Y.
    J Clin Lab Anal; 2018 Feb 25; 32(2):. PubMed ID: 28493512
    [Abstract] [Full Text] [Related]

  • 40. Expression of vascular endothelial growth factor in normal liver and hepatocellular carcinoma: an immunohistochemical study.
    Chow NH, Hsu PI, Lin XZ, Yang HB, Chan SH, Cheng KS, Huang SM, Su IJ.
    Hum Pathol; 1997 Jun 25; 28(6):698-703. PubMed ID: 9191004
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.